You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

148 Results
Drug
Other Name(s): Proleukin® (interleukin-2)
Apr 2024
Drug
Other Name(s): Tomudex®
Sep 2024
Drug
Other Name(s): Torisel ®
Jun 2024
Drug
Other Name(s): Xgeva®; Wyost™
Oct 2024
Drug
Other Name(s): Jevtana®
Nov 2024
Drug
Other Name(s): Yervoy®
Aug 2024
Drug
Other Name(s): Treanda®
Nov 2024
Drug
Other Name(s): Adcetris®
Sep 2024
Drug
Other Name(s): Atriance®
Apr 2024
Drug
Other Name(s): Blincyto®
Nov 2024
Regimen
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Intent: Palliative
Funding:
New Drug Funding Program
    Temsirolimus - Metastatic Renal Cell Carcinoma
Jun 2024
Regimen
Intent: Adjuvant
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Jan 2024

Pages